UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047491
Receipt number R000054157
Scientific Title Factors involved in the onset and course of lymphedema and their treatment.
Date of disclosure of the study information 2022/05/01
Last modified on 2023/10/15 14:58:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Factors involved in the onset and course of lymphedema and their treatment.

Acronym

Factors involved in the onset and course of lymphedema and their treatment.

Scientific Title

Factors involved in the onset and course of lymphedema and their treatment.

Scientific Title:Acronym

Factors involved in the onset and course of lymphedema and their treatment.

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of lifestyle guidance and exercise therapy interventions provided to breast cancer patients during hospitalization and in the postoperative outpatient setting.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Range of motion

Key secondary outcomes

Grip strength
Quick DASH
Circumferential diameter
Questionnaire


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom Other

Interventions/Control_1

At the time of hospitalization and postoperative outpatient treatment, (1) guidance and management regarding prevention of lymphedema onset, (2) exercise therapy for expanding the range of motion of the shoulder joint, and intervention are provided.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(1) Those who have a diagnosis of breast cancer
(2) Women over 20 years old
(3) Surgery with axillary lymph node dissection

Key exclusion criteria

(1) Those with a diagnosis of bilateral breast cancer
(2) Those with a diagnosis of recurrent breast cancer
(3) Those who have a diagnosis of dementia
(4) Those who have a physical or mental illness that requires medical management
(5) Those who have a history of cerebrovascular disease or orthopedic disease

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Masahiro
Middle name
Last name Abo

Organization

The Jikei University School of Medicine

Division name

Department of Rehabilitation Medicine

Zip code

1058471

Address

3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo, Japan

TEL

0334331111

Email

abo@jikei.ac.jp


Public contact

Name of contact person

1st name Daigo
Middle name
Last name Sakamoto

Organization

The Jikei University Graduate School of Medicine

Division name

Department of Rehabilitation Medicine

Zip code

1058471

Address

3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo, Japan

TEL

03-3433-1111

Homepage URL


Email

daigo.0612@jikei.ac.jp


Sponsor or person

Institute

The Jikei University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

None


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Subjects Committee of the Jikei University School of Medicine

Address

3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, Japan

Tel

03-3433-1111

Email

rinri@jikei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 04 Month 18 Day

Date of IRB

2023 Year 03 Month 16 Day

Anticipated trial start date

2023 Year 04 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is ongoing and data is being accumulated.


Management information

Registered date

2022 Year 04 Month 14 Day

Last modified on

2023 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054157


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name